Follow
Shima Moradi-kalbolandi
Shima Moradi-kalbolandi
Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR
No verified email
Title
Cited by
Cited by
Year
Breast cancer: Biology, biomarkers, and treatments
K Barzaman, J Karami, Z Zarei, A Hosseinzadeh, MH Kazemi, ...
International immunopharmacology 84, 106535, 2020
5002020
Potential role of interferons in treating COVID-19 patients
MH Abdolvahab, S Moradi-Kalbolandi, M Zarei, D Bose, K Majidzadeh-A, ...
International immunopharmacology 90, 107171, 2021
772021
Breast cancer immunotherapy: Current and novel approaches
K Barzaman, S Moradi-Kalbolandi, A Hosseinzadeh, MH Kazemi, ...
International immunopharmacology 98, 107886, 2021
622021
Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER
S Moradi-Kalbolandi, A Hosseinzade, M Salehi, P Merikhian, ...
Journal of Pharmacy and Pharmacology 70 (7), 841-854, 2018
392018
The role of mucosal immunity and recombinant probiotics in SARS-CoV2 vaccine development
S Moradi-Kalbolandi, K Majidzadeh-A, MH Abdolvahab, N Jalili, ...
Probiotics and antimicrobial proteins, 1-15, 2021
262021
Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer
G Rezaei, M Habibi-Anbouhi, M Mahmoudi, K Azadmanesh, ...
Nanomedicine 12 (6), 597-613, 2017
222017
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk
K Barzaman, R Vafaei, M Samadi, MH Kazemi, A Hosseinzadeh, ...
Cancer Cell International 22 (1), 259, 2022
152022
Evaluation the potential of recombinant anti-CD3 nanobody on immunomodulatory function
S Moradi-Kalbolandi, A Sharifi-K, B Darvishi, K Majidzadeh-A, S Sadeghi, ...
Molecular immunology 118, 174-181, 2020
152020
Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors
P Merikhian, B Darvishi, N Jalili, MR Esmailinejad, AS Khatibi, ...
Molecular oncology 16 (2), 485-507, 2022
132022
Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo
M Samadi, K Majidzadeh-A, M Salehi, N Jalili, Z Noorinejad, ...
Journal of Biological Engineering 15, 1-15, 2021
132021
Soluble expression and characterization of a new scFv directed to human CD123
S Moradi-Kalbolandi, D Davani, M Golkar, M Habibi-Anbouhi, ...
Applied biochemistry and biotechnology 178, 1390-1406, 2016
122016
Antigenic assessment of a recombinant human CD90 protein expressed in prokaryotic expression system
N Yousefi-Rad, MA Shokrgozar, M Behdani, S Moradi-Kalbolandi, ...
Protein Expression and Purification 116, 139-143, 2015
112015
Development of a novel engineered antibody targeting human CD123
S Moradi-Kalbolandi, M Habibi-Anbouhi, M Golkar, M Behdani, G Rezaei, ...
Analytical biochemistry 511, 27-30, 2016
102016
Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency
K Barzaman, M Samadi, S Moradi-Kalbolandi, K Majidzadeh-A, M Salehi, ...
Experimental Cell Research 405 (2), 112685, 2021
92021
Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti‐ALCAM scFv on breast cancer cells
B Darvishi, M Salehi, S Boroumandieh, K Majidzadeh‐A, N Jalili, ...
Cell Biochemistry and Function 38 (5), 651-659, 2020
72020
Development of an anti-CD45RA-quantum dots conjugated scFv to detect leukemic cancer stem cells
S Moradi-Kalbolandi, F Dashtestani, M Salehi, N Jalili, K Majidzadeh-A, ...
Molecular Biology Reports 47, 225-234, 2020
72020
Enhancement of extracellular bispecific anti‐MUC1 nanobody expression in E. coli BL21 (DE3) by optimization of temperature and carbon sources through an …
L Rezaei, SA Shojaosadati, L Farahmand, S Moradi‐Kalbolandi
Engineering in life sciences 20 (8), 338-349, 2020
52020
Improvement of cytotoxicity and necrosis activity of ganoderic acid a through the development of PMBN-A. Her2-GA as a targeted nano system
PM Fath, M Rahimnejad, S Moradi-Kalbolandi, BE Hosseinzadeh, ...
RSC advances 12 (2), 1228-1237, 2022
32022
Anti-MUC1 nanobody conjugated by chitosan nanoparticle with enhancement of anti-proliferation activity in breast cancer cell lines
F Khodabakhsh, S Shokri, N Jalili, S Moradi-Kalbolandi, F Dashtestani, ...
Chemical Papers 77 (4), 2229-2235, 2023
22023
Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancer
R Vafaei, Z Khaki, M Salehi, N Jalili, MR Esmailinejad, ...
Investigational New Drugs 41 (2), 226-239, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20